Professor of Biochemical Engineering, Vienna University of Technology, Austria
Global Engage is pleased to announce the 2018 Global Bioprocessing and Bioanalytics Congress, which will be held on 24th – 25th May 2018 in Prague, Czech Republic. The event is part of our highly successful series of life science technology congresses including conferences on Biologics & Biosimilars, Pharma R&D Informatics, qPCR and Digital PCR, Medicinal Chemistry, NASH and Precision Medicine amongst others.
The conference will provide an interactive networking forum to both further develop and answer your queries through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, poster presentation sessions, expert led case study presentations, a high-level panel discussion, a roundtable discussion session, and interactive Q&A sessions from a 40-strong speaker faculty examining topics on 4 separate tracks outlined below.
2018 Speakers Include:
Professor and Principal, NIBRT, Ireland and Visiting Investigator, Bioprocessing Technology Institute, AStar, Singapore
Chief Scientist, Global Biologics-Biotech Development and Project Coordinator, Bayer
Biopharmaceutical drug production has seen an unparalleled growth in recent years and is now a core element of the pharmaceutical industry, however, their complexity poses challenges for their manufacturing. New technologies and strategies are needed to produce these drugs efficiently whilst maintaining the high quality and standards required for them to enter the market. This makes it the perfect time, therefore, to learn about the latest technologies and methodologies for pharmaceutical bioprocessing and bioanalytics.
Attracting experts working in all areas of bioprocessing and process analytics, including cell line development, single-use technologies, continuous processing, automated systems, monitoring technologies, CMC/GMP practices, QbD strategies, purification optimisation, and protein recovery, the conference will examine the latest developments in the technologies and methods being used for progressing biologic and biosimilar manufacturing processes.